Prof. Yassine Arabi, MD, FCCP, FCCM
Dr. Arabi obtained his Internal Medicine Training at Wayne State University, Detroit, MI, USA (1992-1994), then he was the Chief Medical Resident at the same institution (1994-1995). He obtained pulmonary and critical care training at the University of Wisconsin, Madison, WI, USA (1995-1998). In 1998, he joined King Abdulaziz Medical City, Riyadh, Saudi Arabia. He is currently the Chairman of the Intensive Care Department and the Medical Director, Respiratory Services. He served as a member of several institutional committees including being the member of several international committees for the Society of Critical Care Medicine (SCCM), American College of Chest Physician (ACCP), and a member of the administrative board of the Saudi Society of Critical Care.
He received multiple grants and awards and he is currently the principal investigator on the PREVENT trial (Prophylaxis of Thromboembolism in Critically Ill Patients Using Combined Intermittent Pneumatic Compression and Pharmacologic Prophylaxis Versus Pharmacologic Prophylaxis Alone: A Multicenter Randomized Controlled Trial); the MIRACLE trial (MERS-CoV Infection tReated with A Combination of Lopinavir /ritonavir and IntErferon beta 1B: a multicenter, placebo-controlled, double-blind randomized trial); the Anti-MERS-COV Convalescent plasma Therapy and the Severe Acute Respiratory Infection Biological Sampling Study. He is also a co-investigator on several multicenter international trials including the ADRENAL (ADjunctive coRticosteriod trEatment iN criticAlly ilL patients with septic shock); SPICE III (A Prospective Multicentre Randomized Controlled Trial of Early Goal Directed Sedation Compared with Standard Care in Mechanically Ventilated Patients in Intensive Care); the OSCILLATE Knowledge Translation – An Audit of ARDS Management ; the PHARLAP study (A multi-centre randomized controlled trial of an Open Lung Strategy Including Permissive Hypercapnia, Alveolar Recruitment and Low Airway Pressure in patients with acute respiratory distress syndrome ) and the SPRINT-SARI (Short PeRiod IncideNce sTudy of Severe Acute Respiratory Infection) among the several others.
Furthermore, he has more than 250 publications including articles in the New England Journal of Medicine (NEJM), JAMA, Lancet, and Critical Care Medicine. He is currently a Section Editor for Intensive Care Medicine and a reviewer of more than 40 high impact international journals as well as granting agencies.
He has also received the following international awards:
Distinguished Scientist Award from Almarai Award for Innovation, Saudi Arabia (2017)
Lifetime Achievement Award from the Saudi Critical Care Society, Saudi Arabia (2013)
Bary A. Shapiro Memorial Award for Excellence in Critical Care Management, Society of Critical Care Medicine, USA (2011)
King Abdullah International Medical Research Center Senior Research Award, Saudi Arabia (2010)
Al-Ghad College Medical Innovation Award, Saudi Arabia (2010)